Ethics Benchmarking Bioethics International runs the Good Pharma Scorecard, an annual benchmarking initiative that increases transparency and accountability in pharma. Sales opportunities exist in offering premium data analytics, benchmarking as a service, or strategic consulting to help companies improve their GPS standing and showcase progress to investors and regulators.

Partnerships & Access Recent collaboration with Yale on the Yale Medicines Access Network highlights BEI’s role in advancing patient access to novel medicines in LMICs. There is potential to offer program design, multi-stakeholder collaboration support, or impact evaluation services to pharma, biotech, and charitable foundations aiming to expand access programs.

Leadership Network The Bioethics Leadership Forum gathers leaders across academia, industry, policy, and investment, signaling opportunities for sponsored events, executive education, and targeted outreach to identify partners and customers seeking ESG-aligned governance and responsible innovation solutions.

Industry Credibility BEI’s long-standing reputation, established since 2005, and partnerships with high-profile institutions (Harvard, NIH collaborations) position it as a trusted advisor on ethics and patient-centric practices. Sales opportunities include strategic advisory, ethical due diligence for investments, and customized compliance frameworks.

Healthcare Focus With a clear mission to align science with patient trust across the medicine lifecycle, BEI presents opportunities to offer education programs, certification, and policy research services to pharmaceutical companies, CROs, and life sciences firms seeking to strengthen patient-centric practices and regulatory alignment.